Pfizer Files Suit Against J and J over Remicade Contracts Caroline Humer | September 20, 2017 Pfizer shares were up 1.3%, or 45 cents, at $35.90 and J&J shares fell 1.6%, or $2.10, to $133.11. The case was filed in the U.S. District Court for the Eastern District of Pennsylvania. ad goes here:advert-1ADVERTISEMENT Page: 1 2 | Single Page Share: